Gilead Sciences, Inc.
NasdaqGS-GILD
Basic
Market Cap
$95.32B
EV
$114.91B
Shares Out
1,245.85M
Revenue
$27.45B
Employees
18,000
Margins
Gross
77.52%
EBITDA
46.14%
Operating
36.15%
Pre-Tax
3.92%
Net
1.77%
FCF
28.78%
Returns (5Yr Avg)
ROA
6.2%
ROTA
-26.44%
ROE
19.05%
ROCE
19.91%
ROIC
16.09%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$82.47
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$5,524M
Net Debt
$19.67B
Debt/Equity
1.44
EBIT/Interest
10.25
Growth (CAGR)
Rev 3Yr
2.4%
Rev 5Yr
4.22%
Rev 10Yr
7.22%
Dil EPS 3Yr
17.45%
Dil EPS 5Yr
-38.82%
Dil EPS 10Yr
-17.63%
Rev Fwd 2Yr
1.54%
EBITDA Fwd 2Yr
2.57%
EPS Fwd 2Yr
3.15%
EPS LT Growth Est
11.12%
Dividends
Yield
—
Payout
776.95%
DPS
$3.02
DPS Growth 3Yr
3.17%
DPS Growth 5Yr
5.23%
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
4.68%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)